Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC)

Alias:

Hlrcc

Multiple Cutaneous and Uterine Leiomyomata

Leiomyomatosis and Renal Cell Cancer

Lrcc

Mcul

Mcl

Hereditary Leiomyomatosis with Renal Carcinoma

Familial Leiomyomatosis and Renal Cell Cancer

Familial Leiomyomatosis with Renal Carcinoma

Multiple Cutaneous and Uterine Leiomyomas

Hereditary Multiple Cutaneous Leiomyomas

Familial Leiomyomatosis Cutis Et Uteri

Familial Multiple Cutaneous Leiomyomas

Hereditary Leiomyomatosis

Reed Syndrome

Mcul1

Multiple Cutaneous and Uterine Leiomyomata 1, with or Without Renal Cell Carcinoma

Multiple Cutaneous and Uterine Leiomyomata 1 with or Without Renal Cell Carcinoma

Hereditary Leiomyomatosis and Renal Cell Carcinoma

Leiomyomatosis and Renal Cell Cancer, Hereditary

Leiomyomatosis and Renal Cell Cancer Hereditary

Leiomyoma, Multiple Cutaneous

Multiple Cutaneous Leiomyomas

Multiple Cutaneous Leiomyoma

Leiomyoma Multiple Cutaneous

Reed's Syndrome

Favorite

Basic Information

Medical Symptom

Gene & Mutation

Related Drugs

Disease Model

References Literature

Hereditary Leiomyomatosis and Renal Cell Cancer, also known as hlrcc, is related to renal cell carcinoma, papillary, 1 and fumarate hydratase deficiency, and has symptoms including flank pain An important gene associated with Hereditary Leiomyomatosis and Renal Cell Cancer is FH (Fumarate Hydratase), and among its related pathways/superpathways are Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. and glycolysis (BioCyc). The drugs Acetylcholine and Atezolizumab have been mentioned in the context of this disorder. Affiliated tissues include kidney and skin, and related phenotypes are abnormality of the musculature and multiple cutaneous leiomyomas

Related ID：

MALACARDS：HRD029

OMIM：150800

MESH：D018231